Loading...

Freeline Therapeutics Holdings plc

FRLN•NASDAQ
Healthcare
Biotechnology
$6.49
$0.010(0.15%)

Freeline Therapeutics Holdings plc (FRLN) Stock Chart & Performance Analysis

Explore Freeline Therapeutics Holdings plc’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.15%
3-Month Change
0.46%
6-Month Change
73.07%
Year-to-Date (YTD) Change
1.56%
1-Year Change
3.02%
3-Year Change
-96.77%
5-Year Change
-97.60%
All-Time (Max) Change
-97.60%

Analyzing Freeline Therapeutics Holdings plc (FRLN) Trends Across Multiple Time Frames

Freeline Therapeutics Holdings plc Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Freeline Therapeutics Holdings plc stock shows N/A 1-day change, indicating low volatility, while its 5-day change of N/A suggests a broader trend. Over a 1-month period, a 0.15% rise could signal a pushback, whereas a 3-month rise of 0.46% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 73.07% and a YTD rise of 1.56% might concern investors, but a 1-year gain of 3.02% and a 3-year drop of -96.77% could indicate resilience. The 5-year surge of -97.60% highlights weak historical growth, while the all-time return of -97.60% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;